Author details

Full Name

Esther Rheinbay

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37385248	Loss of chromosome Y in primary tumors.		2023
37285821	False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay.	Acta Haematol	2023
36652685	Genomics of PDGFR-rearranged hypereosinophilic syndrome.	Blood Adv	2023
36697832	Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.	Nature	2023
34952565	cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries.	BMC Bioinformatics	2021
33626341	Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.	Cell Rep	2021
33981036	RNA transcripts stimulate homologous recombination by forming DR-loops.	Nature	2021
34343496	CXCR6 positions cytotoxic TÂ cells to receive critical survival signals in the tumor microenvironment.	Cell	2021
35121968	The genomic landscape of advanced cancer.	Nature Cancer	2020
33028839	Framework for quality assessment of whole genome cancer sequences.	Nat Commun	2020
29713087	Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29955181	Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29955182	Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29941871	DeTiN: overcoming tumor-in-normal contamination.	Nat Methods	2018
28652578	Rare germline variants in ATM are associated with chronic lymphocytic leukemia.	Leukemia	2017
28892075	Analysis of somatic microsatellite indels identifies driver events in human tumors.	Nat Biotechnol	2017
28658208	Recurrent and functional regulatory mutations in breast cancer.	Nature	2017
26806129	Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.	Cell	2016
26061751	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	N Engl J Med	2015
24726434	Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.	Cell	2014
25453903	EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.	Cancer Cell	2014
25512523	Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.	Proc Natl Acad Sci U S A	2014
23707066	An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.	Cell Rep	2013
23034477	H2A.Z landscapes and dual modifications in pluripotent and multipotent stem cells underlie complex genome regulatory functions.	Genome Biol	2012
22439930	A tell-tail sign of chromatin: histone mutations drive pediatric glioblastoma.	Cancer Cell	2012
22899010	Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.	Genes Dev	2012
20569696	Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network.	Cell Stem Cell	2010
19465905	Evolution of pathogenicity and sexual reproduction in eight Candida genomes.	Nature	2009
18974828	Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains.	PLoS Genet	2008
16563186	Phylogenetic and structural analysis of centromeric DNA and kinetochore proteins.		2006